A Mini Review on Emerging Targets and Approaches for the Synthesis of Anti-viral Compounds: In Perspective to COVID-19

Author(s): Maheswara Rao Gokada, Visweswara Rao Pasupuleti*, Hari Babu Bollikolla*

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 21 , Issue 10 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

The novel Coronavirus disease (COVID-19) is an epidemic disease that appeared at the end of the year 2019 with a sudden increase in number and came to be considered as a pandemic disease caused by a viral infection which has threatened most countries for an emergency search for new anti-SARS-COV drugs /vaccines. At present, the number of clinical trials is ongoing worldwide on different drugs i.e. Hydroxychloroquine, Remedisvir, Favipiravir that utilize various mechanisms of action. A few countries are currently processing clinical trials, which may result in a positive outcome. Favipiravir (FPV) represents one of the feasible treatment options for COVID-19, if the result of the trials turns out positive. Favipiravir will be one of the developed possibly authoritative drugs to warrant benefits to mankind with large-scale production to meet the demands of the current pandemic Covid-19 outbreak and future epidemic outbreaks. In this review, the authors tried to explore key molecules, which will be supportive for devising COVID-19 research.

Keywords: Coronavirus, hydroxychloroquine, remedisvir, favipiravir, mechanism of action, COVID-19.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 10
Year: 2021
Published on: 19 May, 2021
Page: [1173 - 1181]
Pages: 9
DOI: 10.2174/1389557521666210104165733
Price: $65

Article Metrics

PDF: 14